ANG Lifesciences India (BOM:540694) Scaled Net Operating Assets : 0.00 (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is ANG Lifesciences India Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

ANG Lifesciences India's operating assets for the quarter that ended in Dec. 2024 was ₹0 Mil. ANG Lifesciences India's operating liabilities for the quarter that ended in Dec. 2024 was ₹0 Mil. ANG Lifesciences India's Total Assets for the quarter that ended in Sep. 2024 was ₹2,423 Mil. Therefore, ANG Lifesciences India's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2024 was 0.00.

ANG Lifesciences India Scaled Net Operating Assets Historical Data

The historical data trend for ANG Lifesciences India's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ANG Lifesciences India Scaled Net Operating Assets Chart

ANG Lifesciences India Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.67

0.90

1.07

0.52

ANG Lifesciences India Quarterly Data
	Sep19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Scaled Net Operating Assets	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of ANG Lifesciences India's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, ANG Lifesciences India's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ANG Lifesciences India's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ANG Lifesciences India's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where ANG Lifesciences India's Scaled Net Operating Assets falls into.

ANG Lifesciences India Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

ANG Lifesciences India's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Mar. 2024 )
=	(Operating Assets (A: Mar. 2024 )	-	Operating Liabilities (A: Mar. 2024 ))	/	Total Assets (A: Mar. 2023 )
=	(2367.018	-	933.231)	/	2776.617
=	0.52

where

	Operating Assets		(A: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	2424.37	-	57.352
=	2367.018

	Operating Liabilities		(A: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1661.596	-	167.225	-	561.14
=	933.231

ANG Lifesciences India's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2024 )
=	(Operating Assets (Q: Dec. 2024 )	-	Operating Liabilities (Q: Dec. 2024 ))	/	Total Assets (Q: Sep. 2024 )
=	(0	-	0)	/	2422.948
=	0.00

where

	Operating Assets		(Q: Dec. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	0	-	0
=	0

	Operating Liabilities		(Q: Dec. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	0	-	0	-	0
=	0

ANG Lifesciences India Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of ANG Lifesciences India's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

ANG Lifesciences India Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ANG Lifesciences India Ltd (BOM:540694) » Definitions » Scaled Net Operating Assets

Traded in Other Exchanges

N/A

Address

Ranjit Avenue, B-Block, Darbara Complex, SCO 113, First Floor, District Shopping Complex, Amritsar, PB, IND, 143001

Website

https://www.anglifesciences.com

ANG Lifesciences India Ltd is an India-based engaged in the manufacturing of finished pharmaceutical formulations in the form of dry powder for injections. The Group has two reportable segments: Pharmaceuticals which include Manufacturing of pharmaceutical products, and Packaging and printing which include Prinitng and packaging. Key revenue is generated from Pharmaceuticals.

ANG Lifesciences India Headlines

No Headlines